$ATRC
AtriCure, Inc.

2023 Q4 Form 10-Q Financial Statement

#000132388523000110 Filed on November 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $106.5M $98.29M
YoY Change 21.03% 18.07%
Cost Of Revenue $26.73M $24.42M
YoY Change 16.64% 13.41%
Gross Profit $79.82M $73.87M
YoY Change 22.58% 19.7%
Gross Profit Margin 74.91% 75.15%
Selling, General & Admin $66.95M $61.60M
YoY Change 20.63% 7.57%
% of Gross Profit 83.88% 83.4%
Research & Development $20.80M $20.35M
YoY Change 51.27% 34.18%
% of Gross Profit 26.06% 27.55%
Depreciation & Amortization $4.173M $4.110M
YoY Change 42.96% 37.6%
% of Gross Profit 5.23% 5.56%
Operating Expenses $88.48M $81.96M
YoY Change 27.78% 13.15%
Operating Profit -$8.668M -$8.089M
YoY Change 109.57% -24.56%
Interest Expense -$757.0K $1.772M
YoY Change 486.82% 33.84%
% of Operating Profit
Other Income/Expense, Net $9.000K -$62.00K
YoY Change -95.83% -88.71%
Pretax Income -$9.416M -$9.008M
YoY Change 132.55% -26.32%
Income Tax $373.0K $47.00K
% Of Pretax Income
Net Earnings -$9.789M -$9.055M
YoY Change 134.75% -26.21%
Net Earnings / Revenue -9.19% -9.21%
Basic Earnings Per Share -$0.20
Diluted Earnings Per Share -$0.21 -$0.20
COMMON SHARES
Basic Shares Outstanding 47.40M shares 47.35M shares
Diluted Shares Outstanding 46.41M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $137.3M $133.0M
YoY Change 13.35% 8.44%
Cash & Equivalents $84.31M $80.60M
Short-Term Investments $52.98M $52.40M
Other Short-Term Assets $8.563M $6.300M
YoY Change 56.34% 49.22%
Inventory $67.90M $61.89M
Prepaid Expenses
Receivables $52.50M $51.53M
Other Receivables $0.00 $0.00
Total Short-Term Assets $266.2M $252.7M
YoY Change 23.71% 19.05%
LONG-TERM ASSETS
Property, Plant & Equipment $46.76M $45.40M
YoY Change 9.71% 17.75%
Goodwill $234.8M $234.8M
YoY Change 0.0% 0.0%
Intangibles $63.99M $65.68M
YoY Change 62.65% 63.89%
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $2.160M $1.644M
YoY Change 8.82% 98.31%
Total Long-Term Assets $347.7M $347.6M
YoY Change -6.09% -5.97%
TOTAL ASSETS
Total Short-Term Assets $266.2M $252.7M
Total Long-Term Assets $347.7M $347.6M
Total Assets $613.9M $600.3M
YoY Change 4.87% 3.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.35M $24.54M
YoY Change 37.47% 0.56%
Accrued Expenses $44.68M $37.29M
YoY Change 35.31% 19.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.086M $1.100M
YoY Change -74.89% 13.52%
Total Short-Term Liabilities $74.57M $82.54M
YoY Change 27.7% 43.3%
LONG-TERM LIABILITIES
Long-Term Debt $60.59M $42.15M
YoY Change 6.61% -29.82%
Other Long-Term Liabilities $1.234M $1.227M
YoY Change 0.65% 0.33%
Total Long-Term Liabilities $61.83M $43.38M
YoY Change 6.49% -29.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $74.57M $82.54M
Total Long-Term Liabilities $61.83M $43.38M
Total Liabilities $147.8M $137.4M
YoY Change 14.82% 4.43%
SHAREHOLDERS EQUITY
Retained Earnings -$357.1M -$347.3M
YoY Change 9.32% 7.7%
Common Stock $824.2M $812.3M
YoY Change 4.67% 4.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $466.2M $462.8M
YoY Change
Total Liabilities & Shareholders Equity $613.9M $600.3M
YoY Change 4.87% 3.16%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$9.789M -$9.055M
YoY Change 134.75% -26.21%
Depreciation, Depletion And Amortization $4.173M $4.110M
YoY Change 42.96% 37.6%
Cash From Operating Activities $4.034M $1.520M
YoY Change 8669.57% -185.2%
INVESTING ACTIVITIES
Capital Expenditures $2.788M $3.630M
YoY Change -33.16% -170.55%
Acquisitions
YoY Change
Other Investing Activities -$5.000K $15.50M
YoY Change -100.04% 713.22%
Cash From Investing Activities -$2.783M $11.87M
YoY Change -139.75% -466.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.358M 130.0K
YoY Change 18.97% -132.1%
NET CHANGE
Cash From Operating Activities 4.034M 1.520M
Cash From Investing Activities -2.783M 11.87M
Cash From Financing Activities 2.358M 130.0K
Net Change In Cash 3.609M 13.52M
YoY Change -60.03% -349.08%
FREE CASH FLOW
Cash From Operating Activities $4.034M $1.520M
Capital Expenditures $2.788M $3.630M
Free Cash Flow $1.246M -$2.110M
YoY Change -130.21% -162.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Long Term Investments
LongTermInvestments
0 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
41400000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4043000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
65684000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
234781000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1644000 usd
CY2023Q3 us-gaap Assets
Assets
600271000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
24542000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37294000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20702000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
42153000 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
8340000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3180000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
137438000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
47000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
812238000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2184000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-347268000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
462833000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
600271000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.93
us-gaap Net Income Loss
NetIncomeLoss
-20649000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
26416000 usd
us-gaap Depreciation
Depreciation
6979000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3655000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
364000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-461000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8940000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16037000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
828000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4147000 usd
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
400000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
454000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
63815000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9212000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
30000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24603000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
731000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
60000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4873000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6473000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2391000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-167000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22499000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58099000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43654000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80598000 usd
us-gaap Interest Paid Net
InterestPaidNet
4716000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
228000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
714000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1776000 shares
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
761000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
51509000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
38833000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3787000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
39339000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
234781000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1985000 usd
CY2022Q4 us-gaap Assets
Assets
585448000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19898000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33022000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5472000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
82538000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
58392000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
56834000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
9147000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3095000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1227000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1226000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
128694000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47392000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47392000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46563000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46563000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
47000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
787422000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4096000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-326619000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
456754000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
585448000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98290000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83246000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
292702000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
242351000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
24421000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
21533000 usd
us-gaap Cost Of Revenue
CostOfRevenue
72147000 usd
us-gaap Cost Of Revenue
CostOfRevenue
61524000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
73869000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
61713000 usd
us-gaap Gross Profit
GrossProfit
220555000 usd
us-gaap Gross Profit
GrossProfit
180827000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20354000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15169000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53119000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43589000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61604000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57267000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
185451000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
175771000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
81958000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
72436000 usd
us-gaap Operating Expenses
OperatingExpenses
238570000 usd
us-gaap Operating Expenses
OperatingExpenses
219360000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8089000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10723000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-18015000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-38533000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1772000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
1324000 usd
us-gaap Interest Expense
InterestExpense
5127000 usd
us-gaap Interest Expense
InterestExpense
3425000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
915000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
370000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2751000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
562000 usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.93
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46411000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46411000 shares
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9041000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
425000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9055000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
462833000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
483756000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13195000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4347000 usd
us-gaap Net Income Loss
NetIncomeLoss
-42296000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
450308000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
456754000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
24816000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1912000 usd
us-gaap Net Income Loss
NetIncomeLoss
-20649000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
462833000 usd
us-gaap Net Income Loss
NetIncomeLoss
-42296000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
21574000 usd
us-gaap Depreciation
Depreciation
5877000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2914000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
383000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1272000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5710000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-699000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5675000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4314000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4606000 usd
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
442000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22187000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
24637000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
74351000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12710000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
37004000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
662000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3757000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12136000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9041000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-607000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5169000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48823000 usd
us-gaap Interest Paid Net
InterestPaidNet
2926000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
135000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1917000 usd
us-gaap Nature Of Operations
NatureOfOperations
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of the Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The “Company” or “AtriCure” consists of AtriCure, Inc. and its wholly-owned subsidiaries. The Company is a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, and sells its products to medical centers globally through its direct sales force and distributors.</span>
us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including inventories, intangible assets, valuation allowance for deferred income tax assets, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense, including share-based compensation expense. Estimates are based on historical experience, where applicable, and other reasonable assumptions. Actual results could differ from those estimates.</span>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1472000 shares
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
53945000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1529000 usd
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
52416000 usd
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
118221000 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3698000 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
114523000 usd
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2023Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
51670000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
50205000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
2275000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
2211000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
53945000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
52416000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
30086000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19880000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4327000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2959000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
27481000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
23092000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
61894000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
45931000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
76470000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10786000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
46470000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7131000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1699000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
971000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3655000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2914000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1698000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
7453000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
8353000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9553000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
10453000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
28174000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
65684000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
32288000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26924000 usd
CY2023Q3 atrc Sales Returns Allowance Trade
SalesReturnsAllowanceTrade
2870000 usd
CY2022Q4 atrc Sales Returns Allowance Trade
SalesReturnsAllowanceTrade
2797000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2136000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3301000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37294000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33022000 usd
CY2021Q4 atrc Debt Instrument First Required Payment
DebtInstrumentFirstRequiredPayment
P24M
CY2021Q4 atrc Amended Loan Payment Deferral Period
AmendedLoanPaymentDeferralPeriod
P12M
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
3333000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
20000000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
20000000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
16667000 usd
CY2023Q3 atrc Long Term Debt Current Maturities Excluding Fees
LongTermDebtCurrentMaturitiesExcludingFees
18333000 usd
CY2023Q3 atrc Long Term Debt Excluding Current Maturities And Fees
LongTermDebtExcludingCurrentMaturitiesAndFees
41667000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
60000000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y4M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0539
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0460
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P6Y10M24D
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M6D
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0692
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0692
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1250000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
325000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
281000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
960000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
851000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
255000 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
253000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
765000 usd
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
166000 usd
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
182000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
511000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
557000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
421000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
435000 usd
us-gaap Lease Cost
LeaseCost
1276000 usd
us-gaap Lease Cost
LeaseCost
1318000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
905000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
610000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
511000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
557000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
731000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
662000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1068000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
62000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4043000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3787000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1301000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1147000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3180000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3095000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4481000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4242000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
14620000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
14645000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
7849000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
7109000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
6771000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
7536000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1068000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
992000 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
8340000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
9147000 usd
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
9408000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
10139000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
330000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
423000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1270000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1689000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1034000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1638000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
727000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
1671000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
754000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
1703000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1169000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
4824000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5284000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
11948000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
803000 usd
CY2023Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
2540000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4481000 usd
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
9408000 usd
atrc Royalty Rate
RoyaltyRate
0.05
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98290000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83246000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
292702000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
242351000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.005
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.004
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.011
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.004
atrc Share Based Compensation Arrangement By Share Based Payment Award Number Of Share Based Incentive Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfShareBasedIncentivePlans
2 plan
atrc Employee Stock Purchase Plan Offer Period
EmployeeStockPurchasePlanOfferPeriod
P6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
3000 shares
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8661000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7001000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26416000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21574000 usd
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001323885-23-000110-index-headers.html Edgar Link pending
atrc-20230930_lab.xml Edgar Link unprocessable
atrc-20230930_cal.xml Edgar Link unprocessable
atrc-20230930_pre.xml Edgar Link unprocessable
0001323885-23-000110-index.html Edgar Link pending
0001323885-23-000110.txt Edgar Link pending
0001323885-23-000110-xbrl.zip Edgar Link pending
atrc-20230930.htm Edgar Link pending
atrc-20230930.xsd Edgar Link pending
exhibit311-930202310xq.htm Edgar Link pending
exhibit312-930202310xq.htm Edgar Link pending
exhibit321-930202310xq.htm Edgar Link pending
exhibit322-930202310xq.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
atrc-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
atrc-20230930_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending